Abstract
Maintaining glycemic control (blood glucose <180 mg/dL) has been shown to reduce morbidity and enhance long-term survival in patients with diabetes mellitus following coronary artery bypass graft (CABG) surgery. In this review we present a management strategy to achieve perioperative glycemic control in all patients undergoing CABG surgery, with and without diabetes mellitus, designed to achieve compliance with current Surgical Care Improvement Project (SCIP) and Society of Thoracic Surgeons (STS) guidelines.
© 2012 Wiley Periodicals, Inc.
MeSH terms
-
Coronary Artery Bypass*
-
Critical Care / methods
-
Critical Care / standards
-
Diabetes Mellitus, Type 2 / complications
-
Humans
-
Hyperglycemia / diagnosis
-
Hyperglycemia / etiology
-
Hyperglycemia / prevention & control*
-
Hypoglycemic Agents / therapeutic use
-
Insulin / therapeutic use
-
Intraoperative Complications / diagnosis
-
Intraoperative Complications / prevention & control*
-
Patient Discharge
-
Perioperative Care / methods*
-
Perioperative Care / standards
-
Postoperative Complications / diagnosis
-
Postoperative Complications / prevention & control*
-
Practice Guidelines as Topic
Substances
-
Hypoglycemic Agents
-
Insulin